A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
Condition:   Primary Biliary Cirrhosis Interventions:   Drug: TQA3526;   Drug: Placebo to match TQA3526 Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2020 Category: Research Source Type: clinical trials

The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Condition:   Primary Biliary Cirrhosis Intervention:   Sponsors:   Benedetta Terziroli, MD;   Fondazione Epatocentro Ticino;   Vifor Pharma;   Intercept Pharmaceuticals Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials